Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Long-Term Investments (2016 - 2025)

Historic Long-Term Investments for Bio-Techne (TECH) over the last 12 years, with Q4 2025 value amounting to $235.0 million.

  • Bio-Techne's Long-Term Investments fell 261.77% to $235.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $235.0 million, marking a year-over-year decrease of 261.77%. This contributed to the annual value of $236.0 million for FY2025, which is 262.2% down from last year.
  • As of Q4 2025, Bio-Techne's Long-Term Investments stood at $235.0 million, which was down 261.77% from $234.9 million recorded in Q3 2025.
  • Bio-Techne's Long-Term Investments' 5-year high stood at $257.0 million during Q1 2023, with a 5-year trough of $25.0 million in Q2 2022.
  • For the 4-year period, Bio-Techne's Long-Term Investments averaged around $200.5 million, with its median value being $241.3 million (2024).
  • As far as peak fluctuations go, Bio-Techne's Long-Term Investments surged by 92342.8% in 2023, and later tumbled by 528.42% in 2024.
  • Bio-Techne's Long-Term Investments (Quarter) stood at $25.0 million in 2022, then skyrocketed by 898.92% to $249.7 million in 2023, then decreased by 3.35% to $241.4 million in 2024, then fell by 2.62% to $235.0 million in 2025.
  • Its last three reported values are $235.0 million in Q4 2025, $234.9 million for Q3 2025, and $236.0 million during Q2 2025.